Cargando…

Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure

BACKGROUND: Whereas the risk factors for structural valve degeneration (SVD) of glutaraldehyde‐treated bioprosthetic heart valves (BHVs) are well studied, those responsible for the failure of BHVs fixed with alternative next‐generation chemicals remain largely unknown. This study aimed to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostyunin, Alexander E., Glushkova, Tatiana V., Lobov, Arseniy A., Ovcharenko, Evgeny A., Zainullina, Bozhana R., Bogdanov, Leo A., Shishkova, Daria K., Markova, Victoria E., Asanov, Maksim A., Mukhamadiyarov, Rinat A., Velikanova, Elena A., Akentyeva, Tatiana N., Rezvova, Maria A., Stasev, Alexander N., Evtushenko, Alexey V., Barbarash, Leonid S., Kutikhin, Anton G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973599/
https://www.ncbi.nlm.nih.gov/pubmed/36565196
http://dx.doi.org/10.1161/JAHA.122.028215
_version_ 1784898561082654720
author Kostyunin, Alexander E.
Glushkova, Tatiana V.
Lobov, Arseniy A.
Ovcharenko, Evgeny A.
Zainullina, Bozhana R.
Bogdanov, Leo A.
Shishkova, Daria K.
Markova, Victoria E.
Asanov, Maksim A.
Mukhamadiyarov, Rinat A.
Velikanova, Elena A.
Akentyeva, Tatiana N.
Rezvova, Maria A.
Stasev, Alexander N.
Evtushenko, Alexey V.
Barbarash, Leonid S.
Kutikhin, Anton G.
author_facet Kostyunin, Alexander E.
Glushkova, Tatiana V.
Lobov, Arseniy A.
Ovcharenko, Evgeny A.
Zainullina, Bozhana R.
Bogdanov, Leo A.
Shishkova, Daria K.
Markova, Victoria E.
Asanov, Maksim A.
Mukhamadiyarov, Rinat A.
Velikanova, Elena A.
Akentyeva, Tatiana N.
Rezvova, Maria A.
Stasev, Alexander N.
Evtushenko, Alexey V.
Barbarash, Leonid S.
Kutikhin, Anton G.
author_sort Kostyunin, Alexander E.
collection PubMed
description BACKGROUND: Whereas the risk factors for structural valve degeneration (SVD) of glutaraldehyde‐treated bioprosthetic heart valves (BHVs) are well studied, those responsible for the failure of BHVs fixed with alternative next‐generation chemicals remain largely unknown. This study aimed to investigate the reasons behind the development of SVD in ethylene glycol diglycidyl ether–treated BHVs. METHODS AND RESULTS: Ten ethylene glycol diglycidyl ether–treated BHVs excised because of SVD, and 5 calcified aortic valves (AVs) replaced with BHVs because of calcific AV disease were collected and their proteomic profile was deciphered. Then, BHVs and AVs were interrogated for immune cell infiltration, microbial contamination, distribution of matrix‐degrading enzymes and their tissue inhibitors, lipid deposition, and calcification. In contrast with dysfunctional AVs, failing BHVs suffered from complement‐driven neutrophil invasion, excessive proteolysis, unwanted coagulation, and lipid deposition. Neutrophil infiltration was triggered by an asymptomatic bacterial colonization of the prosthetic tissue. Neutrophil elastase, myeloblastin/proteinase 3, cathepsin G, and matrix metalloproteinases (MMPs; neutrophil‐derived MMP‐8 and plasma‐derived MMP‐9), were significantly overexpressed, while tissue inhibitors of metalloproteinases 1/2 were downregulated in the BHVs as compared with AVs, together indicative of unbalanced proteolysis in the failing BHVs. As opposed to other proteases, MMP‐9 was mostly expressed in the disorganized prosthetic extracellular matrix, suggesting plasma‐derived proteases as the primary culprit of SVD in ethylene glycol diglycidyl ether–treated BHVs. Hence, hemodynamic stress and progressive accumulation of proteases led to the extracellular matrix degeneration and dystrophic calcification, ultimately resulting in SVD. CONCLUSIONS: Neutrophil‐ and plasma‐derived proteases are responsible for the loss of BHV mechanical competence and need to be thwarted to prevent SVD.
format Online
Article
Text
id pubmed-9973599
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99735992023-03-01 Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure Kostyunin, Alexander E. Glushkova, Tatiana V. Lobov, Arseniy A. Ovcharenko, Evgeny A. Zainullina, Bozhana R. Bogdanov, Leo A. Shishkova, Daria K. Markova, Victoria E. Asanov, Maksim A. Mukhamadiyarov, Rinat A. Velikanova, Elena A. Akentyeva, Tatiana N. Rezvova, Maria A. Stasev, Alexander N. Evtushenko, Alexey V. Barbarash, Leonid S. Kutikhin, Anton G. J Am Heart Assoc Original Research BACKGROUND: Whereas the risk factors for structural valve degeneration (SVD) of glutaraldehyde‐treated bioprosthetic heart valves (BHVs) are well studied, those responsible for the failure of BHVs fixed with alternative next‐generation chemicals remain largely unknown. This study aimed to investigate the reasons behind the development of SVD in ethylene glycol diglycidyl ether–treated BHVs. METHODS AND RESULTS: Ten ethylene glycol diglycidyl ether–treated BHVs excised because of SVD, and 5 calcified aortic valves (AVs) replaced with BHVs because of calcific AV disease were collected and their proteomic profile was deciphered. Then, BHVs and AVs were interrogated for immune cell infiltration, microbial contamination, distribution of matrix‐degrading enzymes and their tissue inhibitors, lipid deposition, and calcification. In contrast with dysfunctional AVs, failing BHVs suffered from complement‐driven neutrophil invasion, excessive proteolysis, unwanted coagulation, and lipid deposition. Neutrophil infiltration was triggered by an asymptomatic bacterial colonization of the prosthetic tissue. Neutrophil elastase, myeloblastin/proteinase 3, cathepsin G, and matrix metalloproteinases (MMPs; neutrophil‐derived MMP‐8 and plasma‐derived MMP‐9), were significantly overexpressed, while tissue inhibitors of metalloproteinases 1/2 were downregulated in the BHVs as compared with AVs, together indicative of unbalanced proteolysis in the failing BHVs. As opposed to other proteases, MMP‐9 was mostly expressed in the disorganized prosthetic extracellular matrix, suggesting plasma‐derived proteases as the primary culprit of SVD in ethylene glycol diglycidyl ether–treated BHVs. Hence, hemodynamic stress and progressive accumulation of proteases led to the extracellular matrix degeneration and dystrophic calcification, ultimately resulting in SVD. CONCLUSIONS: Neutrophil‐ and plasma‐derived proteases are responsible for the loss of BHV mechanical competence and need to be thwarted to prevent SVD. John Wiley and Sons Inc. 2022-12-24 /pmc/articles/PMC9973599/ /pubmed/36565196 http://dx.doi.org/10.1161/JAHA.122.028215 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Kostyunin, Alexander E.
Glushkova, Tatiana V.
Lobov, Arseniy A.
Ovcharenko, Evgeny A.
Zainullina, Bozhana R.
Bogdanov, Leo A.
Shishkova, Daria K.
Markova, Victoria E.
Asanov, Maksim A.
Mukhamadiyarov, Rinat A.
Velikanova, Elena A.
Akentyeva, Tatiana N.
Rezvova, Maria A.
Stasev, Alexander N.
Evtushenko, Alexey V.
Barbarash, Leonid S.
Kutikhin, Anton G.
Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure
title Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure
title_full Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure
title_fullStr Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure
title_full_unstemmed Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure
title_short Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure
title_sort proteolytic degradation is a major contributor to bioprosthetic heart valve failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973599/
https://www.ncbi.nlm.nih.gov/pubmed/36565196
http://dx.doi.org/10.1161/JAHA.122.028215
work_keys_str_mv AT kostyuninalexandere proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT glushkovatatianav proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT lobovarseniya proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT ovcharenkoevgenya proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT zainullinabozhanar proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT bogdanovleoa proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT shishkovadariak proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT markovavictoriae proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT asanovmaksima proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT mukhamadiyarovrinata proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT velikanovaelenaa proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT akentyevatatianan proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT rezvovamariaa proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT stasevalexandern proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT evtushenkoalexeyv proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT barbarashleonids proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure
AT kutikhinantong proteolyticdegradationisamajorcontributortobioprostheticheartvalvefailure